ABVC BioPharma, Inc.
ABVC
$1.00
-$0.06-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -68.18% | -196.37% | -61.30% | -11.47% | 43.49% |
| Total Depreciation and Amortization | 175.00% | 127.51% | 151.22% | -75.33% | -69.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.56% | 295.57% | 52.46% | 19.86% | -43.18% |
| Change in Net Operating Assets | 76.66% | -698.65% | -50.62% | -47.31% | 1.59% |
| Cash from Operations | -29.63% | -139.80% | -65.07% | -47.60% | 29.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -263.89% | -- | -- | -389.89% | 58.95% |
| Cash from Investing | -263.89% | -- | -- | -389.89% | 61.02% |
| Total Debt Issued | 226.06% | 1,381.67% | 138.91% | -99.47% | -60.43% |
| Total Debt Repaid | -147.16% | -206.23% | -53.83% | -68.52% | -146.38% |
| Issuance of Common Stock | -31.24% | 209.78% | 339.12% | 326.17% | 179.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -134.66% | -100.00% | 17.82% | -79.59% |
| Cash from Financing | -17.03% | 160.33% | 134.16% | 127.19% | -23.70% |
| Foreign Exchange rate Adjustments | 311.38% | 92.77% | 182.11% | 105.92% | 13.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -413.07% | -715.51% | 215.17% | 123.95% | 66,620.00% |